KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Change in Inventory: 2009-2025

Historic Change in Inventory for Colgate Palmolive (CL) over the last 17 years, with Sep 2025 value amounting to -$6.0 million.

  • Colgate Palmolive's Change in Inventory fell 107.79% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 106.00%. This contributed to the annual value of $100.0 million for FY2024, which is 151.55% up from last year.
  • Latest data reveals that Colgate Palmolive reported Change in Inventory of -$6.0 million as of Q3 2025, which was up 93.26% from -$89.0 million recorded in Q2 2025.
  • In the past 5 years, Colgate Palmolive's Change in Inventory registered a high of $215.0 million during Q1 2022, and its lowest value of -$96.0 million during Q3 2023.
  • Its 3-year average for Change in Inventory is -$9.4 million, with a median of -$6.0 million in 2025.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 11,800.00% in 2022, then tumbled by 417.86% in 2025.
  • Colgate Palmolive's Change in Inventory (Quarterly) stood at $35.0 million in 2021, then plummeted by 354.29% to -$89.0 million in 2022, then soared by 50.56% to -$44.0 million in 2023, then skyrocketed by 113.64% to $6.0 million in 2024, then tumbled by 107.79% to -$6.0 million in 2025.
  • Its Change in Inventory stands at -$6.0 million for Q3 2025, versus -$89.0 million for Q2 2025 and $86.0 million for Q1 2025.